1 asset in Combined Pituitary Hormone Deficiencies, Genetic Form

Therapeutic assets addressing Combined Pituitary Hormone Deficiencies, Genetic Form, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Setmelanotide Combined Pituitary Hormone Deficiencies, Genetic Form	Rhythm Pharmaceuticals, Inc.	P3	B (60)